Status:
RECRUITING
CRISAL Study:Cancer Risk In Secreting Adrenal Lesions
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Adrenal Tumor
Adrenal Incidentaloma
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the present study is to report the cancer risk in secreting adrenal lesions. Secondary aims: to compare the incidence of cancer in secreting versus non-secreting adrenal lesions, in order t...
Detailed Description
Background: The risk of adrenal cancer increases with increasing lesion size. Up to 60% of malignant adrenal lesions have hormonal activity and that hypercortisolism is strongly suggestive of malignan...
Eligibility Criteria
Inclusion
- Patients undergoing elective adrenalectomy;
- Patients aged ≥ 18 years
- Acceptance of informed consent
Exclusion
- Patients undergoing emergency adrenalectomy;
- Patients aged ≤ 18 years
- Pregnant patients
Key Trial Info
Start Date :
August 27 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 10 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06520111
Start Date
August 27 2024
End Date
November 10 2024
Last Update
August 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General and Mininvasive Surgery Department, Pederzoli Hospital,
Peschiera del Garda, Verona, Italy., Italy